- Conditions
- DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- Highlands Oncology Group Bentonville, Arkansas, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
1,618 public trials
340 recruiting studies
Lymphoma, B-Cell trial results
Completed
Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
NCT00599170
- Conditions
- Diffuse, Large B-Cell, Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT05113576
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT04317313
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT04697160
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- MorphoSys Research Site Scottsdale, Arizona, United States
- MorphoSys Research Site Clovis, California, United States
- MorphoSys Research Site Los Angeles, California, United States
- MorphoSys Research Site Orange, California, United States
NCT03576443
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Aarhus University Hospital Aarhus C, Denmark
- Odense University Hospital Odense, Denmark
- Halmstad County Hospital Halmstad, Sweden
- Linkoping University Hospital Linköping, Sweden
Completed
Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia
NCT02808442
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- Hôpital Robert-Debré Paris, France
NCT01353625
- Conditions
- Astrocytoma, Blood Protein Disorders, Carcinoma, +52 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
NCT02746952
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Hôpital Saint-Louis Paris, France